$22.91
Landos Biopharma Inc is a biotechnology business based in the US. Landos Biopharma Inc shares (LABP) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.00 – the same closing value as a week prior. Landos Biopharma Inc employs 19 staff and has a market cap (total outstanding shares value) of 0.00.
What's in this guide?
Our top picks for where to buy Landos Biopharma stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Landos Biopharma Inc stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – LABP. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Landos Biopharma Inc stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Landos Biopharma Inc stock price (NASDAQ: LABP)
Use our graph to track the performance of LABP stocks over time.Landos Biopharma Inc shares at a glance
Latest market close | $0.00 |
---|---|
52-week range | $3.15 - $22.94 |
50-day moving average | $20.19 |
200-day moving average | $8.35 |
Wall St. target price | $12.71 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-4.00 |
Is it a good time to buy Landos Biopharma Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Landos Biopharma Inc price performance over time
Historical closes compared with the close of $0 from 2024-06-11
1 week (2024-10-12) | N/A |
---|---|
1 month (2024-09-19) | N/A |
3 months (2024-07-19) | N/A |
6 months (2024-04-23) | -100.00% |
1 year (2023-10-23) | -100.00% |
---|---|
2 years (2022-10-21) | -100.00% |
3 years (2021-10-22) | 13.84 |
5 years (2019-10-19) | N/A |
Landos Biopharma Inc financials
Gross profit TTM | $18 million |
---|---|
Return on assets TTM | -39.38% |
Return on equity TTM | -70.67% |
Profit margin | 0% |
Book value | $7.43 |
Market Capitalization | $71.7 million |
TTM: trailing 12 months
Landos Biopharma Inc share dividends
We're not expecting Landos Biopharma Inc to pay a dividend over the next 12 months.
You may also wish to consider:
Have Landos Biopharma Inc's shares ever split?
Landos Biopharma Inc's shares were split on a 1:10 basis on 25 May 2023 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Landos Biopharma Inc shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Landos Biopharma Inc shares which in turn could have impacted Landos Biopharma Inc's share price.
Landos Biopharma Inc share price volatility
Over the last 12 months, Landos Biopharma Inc's shares have ranged in value from as little as $3.145 up to $22.94. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Landos Biopharma Inc's is 0.143. This would suggest that Landos Biopharma Inc's shares are less volatile than average (for this exchange).
To put Landos Biopharma Inc's beta into context you can compare it against those of similar companies.
- Leap Therapeutics (LPTX.US): 0.274
- Allakos (ALLK.US): 1.151
Landos Biopharma Inc overview
Landos Biopharma, Inc. , a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. Its lead product candidate is NX-13, an oral gut-selective Nucleotide Oligomerization Domain (NLRX1), a mitochondria-associated receptor associated with the modulation of inflammatory cytokines that is in Phase 2 clinical trial to treat ulcerative colitis (UC) and completed Phase 1 to treat Crohn's disease (CD). The company's preclinical candidates in development include LABP-73, an oral and small molecule NLRX1 pathway agonist for the treatment of asthma and eosinophilic disorders; LABP-66 is an oral and small molecule NLRX1 pathway agonist for the treatment of multiple sclerosis and neurodegenerative disorders; and LABP-69, an oral PLXDC2 agonist for the treatment of rheumatoid arthritis, UC, and CD. The company has a license and collaboration agreement with LianBio Respiratory Limited to develop, manufacture, and commercialize omilancor and NX-13. Landos Biopharma, Inc. was incorporated in 2017 and is headquartered in Blacksburg, Virginia.
Frequently asked questions
What percentage of Landos Biopharma Inc is owned by insiders or institutions?Currently 9.888% of Landos Biopharma Inc shares are held by insiders and 52.041% by institutions. How many people work for Landos Biopharma Inc?
Latest data suggests 19 work at Landos Biopharma Inc. When does the fiscal year end for Landos Biopharma Inc?
Landos Biopharma Inc's fiscal year ends in December. Where is Landos Biopharma Inc based?
Landos Biopharma Inc's address is: 1800 Kraft Drive, Blacksburg, VA, United States, 24060 What is Landos Biopharma Inc's ISIN number?
Landos Biopharma Inc's international securities identification number is: US5150691021
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Best broker cash sweep rates of 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
Public.com Review 2024: No-Fee Options, With Rebates
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question